E Fund Management Co., Ltd. Care Dx, Inc. Transaction History

E Fund Management Co., Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.96 - $12.37 $56,309 - $87,505	7,074 Added 69.59%	17,239 $182,000
Q4 2023 Feb 06, 2024	SELL	$4.9 - $12.86 $27,038 - $70,961	-5,518 Reduced 35.18%	10,165 $121,000
Q3 2023 Nov 13, 2023	SELL	$7.0 - $11.26 $19,278 - $31,010	-2,754 Reduced 14.94%	15,683 $110,000
Q2 2023 Aug 11, 2023	SELL	$7.61 - $9.46 $35,652 - $44,320	-4,685 Reduced 20.26%	18,437 $157,000
Q1 2023 May 11, 2023	SELL	$8.83 - $17.61 $20,600 - $41,084	-2,333 Reduced 9.17%	23,122 $211,000
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $58,556 - $107,909	5,382 Added 26.81%	25,455 $290,000
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $12,591 - $20,689	784 Added 4.06%	20,073 $342,000
Q2 2022 Aug 15, 2022	BUY	$20.49 - $39.72 $216,661 - $419,999	10,574 Added 121.33%	19,289 $414,000
Q1 2022 May 12, 2022	BUY	$28.19 - $46.6 $187,801 - $310,449	6,662 Added 324.5%	8,715 $322,000
Q1 2021 May 12, 2021	BUY	$57.62 - $95.6 $118,293 - $196,266	2,053 New	2,053 $139,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.